Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parikh

Showing results (1011-1020 of 1,087) with videos related to

Pageof 109
Sort By:
Plos One|March 3, 2022
Clinically adjudicated deceased donor acute kidney injury and graft outcomesSherry G Mansour, Nadeen Khoury, Ravi Kodali, et al.
BMC Cancer|April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic diseaseNeil R Parikh, Claudia Huiza, Jill S Patel, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2019
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical TrialAmit X Garg, Neal Badner, Sean M Bagshaw, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
COVID-19-associated AKI in hospitalized US patients: incidence, temporal trends, geographical distribution, risk factors and mortalityYun Jae Yoo, Kenneth J Wilkins, Fadhl Alakwaa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate CancerAmy J Wisdom, Beow Y Yeap, Jeff M Michalski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 3, 2023
Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort CollaborativeYun J Yoo, Kenneth J Wilkins, Fadhl Alakwaa, et al.
American Journal of Clinical Oncology|May 20, 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic CholangiocarcinomaGrace Lee, Daniel W Kim, Alicia C Smart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 28, 2023
Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing OutcomesGeorge Vasquez-Rios, Wonsuk Oh, Samuel Lee, et al.
American Journal of Nephrology|June 30, 2025
Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four CohortsCarolina Lopez-Silva, Aditya Surapaneni, Josef Coresh, et al.
Kidney International|July 3, 2019
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injuryAlexander L Bullen, Ronit Katz, Alexandra K Lee, et al.
Pageof 109

Showing results (1011-1020 of 1,087) with videos related to

Sort By:
Pageof 109
Plos One|March 3, 2022
Clinically adjudicated deceased donor acute kidney injury and graft outcomesSherry G Mansour, Nadeen Khoury, Ravi Kodali, et al.
BMC Cancer|April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic diseaseNeil R Parikh, Claudia Huiza, Jill S Patel, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2019
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical TrialAmit X Garg, Neal Badner, Sean M Bagshaw, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
COVID-19-associated AKI in hospitalized US patients: incidence, temporal trends, geographical distribution, risk factors and mortalityYun Jae Yoo, Kenneth J Wilkins, Fadhl Alakwaa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate CancerAmy J Wisdom, Beow Y Yeap, Jeff M Michalski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 3, 2023
Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort CollaborativeYun J Yoo, Kenneth J Wilkins, Fadhl Alakwaa, et al.
American Journal of Clinical Oncology|May 20, 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic CholangiocarcinomaGrace Lee, Daniel W Kim, Alicia C Smart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 28, 2023
Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing OutcomesGeorge Vasquez-Rios, Wonsuk Oh, Samuel Lee, et al.
American Journal of Nephrology|June 30, 2025
Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four CohortsCarolina Lopez-Silva, Aditya Surapaneni, Josef Coresh, et al.
Kidney International|July 3, 2019
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injuryAlexander L Bullen, Ronit Katz, Alexandra K Lee, et al.
Pageof 109